Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for lung cancer patients with tough brain spread

NCT ID NCT07398599

Summary

This study is testing a more intensive treatment for people with advanced lung cancer where the disease has spread to the lining of the brain and spine, and has gotten worse despite standard targeted therapy. About 30 participants will receive a higher dose of their targeted pill, plus two other drugs given into the bloodstream and directly into the spinal fluid. The main goal is to see if this combination can better control the cancer in the brain and spine and to monitor side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Second Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, Jiangxi, China

Conditions

Explore the condition pages connected to this study.